Up to €600 savings end in:
- 00Days
- 00Hrs
- 00Mins
- 00Secs
March 23–25, 2026
FIL (Feira Internacional de Lisboa), Lisbon, PortugalMarch 31 – April 1, 2026 | Digital Partnering Christina CoughlinCEO at AvactaSpeaker
Profile
Christina Coughlin is the CEO of Avacta Therapeutics, a clinical stage biopharmaceutical company developing pre|CISION®, a tumor-activated oncology delivery platform. She is the former CEO of CytoImmune Therapeutics, and prior to that role, she held multiple CMO positions in biotechnology companies including Rubius Therapeutics and Immunocore where she led the development of Kimmtrak®. Dr. Coughlin has nearly 20 years of industry experience including leadership roles at Pfizer, Novartis and Wyeth. Dr. Coughlin is an oncologist and immunologist, having received her M.D. and Ph.D. from the University of Pennsylvania.
Agenda Sessions
Charting the current of innovation and opportunity in oncology
, 14:30View Session